Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insiders May Be Concerned about Gloomy Outlook of These Companies; Should You be Worried too?

Page 1 of 2

It is widely known that the trading activity of corporate insiders may provide useful insights about a company’s future prospects. Similarly, various studies have also suggested that insiders tend to act in the fashion of value-oriented investors. It is also true that insider buying activity might be more valuable than insider selling activity on some occasions, as the latter one may occur for numerous reasons unrelated to a company’s outlook. Even so, insiders’ sell-offs may sometimes point to a struggling future at their companies, so this type of activity may be sometimes worthwhile to the same extend as insider buying. In the following article we will investigate the insider selling activity at these three companies: Spirit AeroSystems Holdings Inc. (NYSE:SPR), Healthequity Inc. (NASDAQ:HQY), and Ashland Inc. (NYSE:ASH). Let us also remind you that the Insider Monkey team ignores the insider sales handled by trading plans, which emphasizes the significance of the impromptu trades conducted by corporate insiders.

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 118% over the ensuing 36 months, outperforming the S&P 500 Index by nearly 61 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Moving back to our three theoretically “gloomy-outlook” stocks, Spirit AeroSystems Holdings Inc. (NYSE:SPR) had one of its executives sell stock earlier this week. Samantha J. Marnick, Chief Administrative Officer and Senior Vice President, sold 8,000 shares at a weighted average price of $49.54, reducing her holding to 62,544 shares. Spirt operates as a non-original equipment manufacturer that designs, engineers, and manufacturers commercial aircraft structures, and worked on all Boeing Co (NYSE:BA)’s programs. Boeing had delivered 503 commercial aircrafts by the end of the previous month and is on the track of beating previous year’s record delivery of 723 commercial aircrafts. Hence, it is hardly unlikely that Spirit AeroSystems will face major challenges in the months ahead. The company’s stock performance has been quite strong this year as well, with its shares advancing 15% year-to-date. However, Matt Sirovich and Jeremy Mindich’s Scopia Capital, the largest shareholder of Spirit AeroSystems Holdings Inc. (NYSE:SPR) within our database, revealed trimming its stake to 14.72 million shares a little over a month ago.

Follow Spirit Aerosystems Holdings Inc. (NYSE:SPR)
Trade (NYSE:SPR) Now!
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!